Drug Profile
Research programme: SCPF - Advanced Tissue Sciences
Alternative Names: SCPFLatest Information Update: 25 Aug 2006
Price :
$50
*
At a glance
- Originator Advanced Tissue Sciences [CEASED]
- Class Antineoplastics; Radioprotectives
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 25 Aug 2006 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 18 Oct 2002 Advanced Tissue Sciences has filed under Chapter 11 of the US Bankruptcy Code
- 25 Jun 2001 No-Development-Reported for Cancer in USA (Unknown route)